Treatment continuum
Polysubstance rehab.
Treatment for polysubstance use — alcohol with benzodiazepines, opioids with stimulants, multiple substances used concurrently. Polysubstance presentations are now the norm in addiction medicine, not the exception, and require integrated clinical management.
Overview
Polysubstance rehab is the structured, professionally supervised treatment of multiple concurrent substance use disorders across the full continuum of care. Polysubstance presentations — alcohol with benzodiazepines, opioids with stimulants, multiple opioids, cannabis with everything else — are now the norm in addiction medicine, not the exception. The fentanyl contamination of the U.S. drug supply has driven a substantial share of fatal overdoses that involve stimulants, benzodiazepines, or other substances that the user did not intend to consume. Clinical management of polysubstance use is more complex than single-substance treatment: withdrawal protocols must address multiple substances simultaneously, medication-assisted treatment options vary by substance, co-occurring mental health conditions are nearly universal, and continuing-care planning has to account for multiple recovery domains. SILC Health operates licensed polysubstance treatment programs in California and Georgia, accepts most major commercial insurance, and integrates ASAM Level 3.7 medical detox with residential, PHP, and IOP step-down as clinically indicated.
Medically reviewed by Peter Scheid, MD
Medical Director, SILC Health
Clinically reviewed by Alexandra Truman, LMFT
Clinical Director, Substance Use Services — SILC Health
Last reviewed: June 16, 2026
Section 1
What this is.
Polysubstance use refers to the concurrent use of multiple psychoactive substances — alcohol plus benzodiazepines, opioids plus stimulants, multiple opioids, cannabis combined with other substances. Under DSM-5, each substance use disorder is diagnosed and severity-graded separately, but clinical management has to address the polysubstance picture as a whole. The presence of multiple substances changes withdrawal management, medication-assisted treatment selection, and the risk profile of any given treatment decision.
The fentanyl contamination of the U.S. drug supply has materially raised the stakes of polysubstance use. Fentanyl is now detected in seized counterfeit pressed pills (presented as oxycodone, alprazolam, or Adderall), in cocaine and methamphetamine supplies, and in heroin. Many overdose decedents had no intention of using opioids — they purchased what they believed to be a different substance. SILC's clinical protocols treat any polysubstance presentation as potentially opioid-exposed: naloxone education, opioid-receptor screening, and the possibility of opioid use disorder treatment are part of standard programming.
Polysubstance use is closely associated with co-occurring mental health conditions: depression, anxiety, PTSD, bipolar disorder, ADHD, and personality disorders are nearly universal in clients presenting for polysubstance treatment. Treating one substance use disorder while ignoring the others — or treating any substance use disorder without addressing co-occurring psychiatric conditions — is a recipe for relapse. SILC's clinical model treats the whole presentation concurrently, with individualized care plans built around the specific combination each client presents with.
Fentanyl contamination
Fentanyl is now detected in counterfeit pressed pills, cocaine, methamphetamine, and heroin supplies. A substantial share of overdose decedents had no intention of using opioids — the substance they purchased was contaminated.
ASAM 3.7
Most polysubstance presentations meet criteria for ASAM Level 3.7 medical detox — medically managed inpatient withdrawal with 24/7 nursing — before transitioning to residential treatment.
Section 2
The continuum of care.
1. Medical detox (5–10 days, ASAM Level 3.7)
Polysubstance detox at SILC is medically managed with 24/7 nursing and physician oversight. Withdrawal symptoms are managed pharmacologically; vitals and cognitive status are monitored continuously; complications are escalated immediately. Detox is the foundation — the work that follows is harder without it. See more →
2. Residential treatment (30 / 60 / 90+ days, ASAM Level 3.1–3.5)
Residential — sometimes called "inpatient" — is the longest and most intensive phase. Clients live on-site, participate in structured clinical programming daily, attend individual and group therapy, work with family when appropriate, build recovery skills, and stabilize physically and emotionally. Length of stay is clinically determined; most clients with moderate-to-severe substance use disorder benefit from at least 60 days.
3. Partial Hospitalization (PHP) — day treatment (ASAM Level 2.5)
PHP is the first step down from 24-hour residential care. Clients spend most of the day in clinical programming (typically 5–6 days per week, 5–6 hours per day) but return to sober living or stable housing each night. PHP supports reintegration into community life while still providing intensive clinical structure.
4. Intensive Outpatient (IOP) — 9–15 hours weekly (ASAM Level 2.1)
IOP runs 9–15 hours per week across 3 days, allowing return to work, school, or family responsibilities. Clinical focus shifts toward relapse prevention, ongoing therapy, and community reintegration. IOP often runs in parallel with recovery fellowship participation.
5. Outpatient + aftercare (indefinite)
Standard outpatient — individual therapy, psychiatric medication management when indicated, group therapy with a community provider — extends after IOP and continues indefinitely. Aftercare also includes recovery fellowship participation, sober living when appropriate, and ongoing alumni programming.
Section 3
Who this is for.
Polysubstance use disorder requires residential or higher levels of care more often than single-substance presentations. Residential polysubstance rehab is clearly indicated for: any combination involving alcohol or benzodiazepines plus other substances (the withdrawal risk profile alone often requires ASAM Level 3.7 medical detox), opioid use combined with any other substance (fentanyl exposure risk), three or more substances used regularly, co-occurring mental health conditions complicating recovery, prior treatment episodes that did not adequately address the polysubstance picture, or any environment where structured 24-hour clinical management is needed for safe stabilization.
ASAM criteria match the polysubstance presentation to the appropriate level of care. Most polysubstance presentations meet criteria for ASAM Level 3.7 medical detox (medically managed inpatient withdrawal with 24/7 nursing) before transitioning to residential addiction treatment. The integrated detox-to-residential pathway at SILC's California and Georgia facilities is built for exactly this clinical pattern.
Continuing care after residential polysubstance treatment is more complex than single-substance discharge planning. Multiple medication-assisted treatments may need to continue (e.g., buprenorphine for opioid use disorder plus naltrexone for alcohol use disorder), psychiatric care for co-occurring conditions must be coordinated, and the recovery community engagement plan has to address multiple substances. SILC's clinical team builds these multi-domain discharge plans before residential treatment ends.
Section 4
A day in residential.
Residential polysubstance rehab is structured but not regimented. Most days at a SILC facility follow a clinical rhythm designed to balance therapeutic work, peer connection, physical wellness, and rest.
- •Morning: Wake, vitals check during detox phase, mindfulness or meditation, breakfast, community meeting.
- •Mid-morning to lunch: Individual therapy session or process group; psychiatric or medical check-ins when relevant.
- •Afternoon: Skill-building group (CBT, DBT, relapse prevention), or experiential work (movement, art, equine therapy depending on facility), or family session when scheduled.
- •Late afternoon: Physical wellness (exercise, beach walk at coastal California facilities, fitness room), peer time, dinner.
- •Evening: Recovery fellowship meeting (AA, SMART, or alternative), reflection group, journaling, rest.
Family communication is supported per the client's preference. Family programming — visits, family therapy sessions, and structured education on supporting recovery — is clinically encouraged once initial stabilization is complete, typically after the first 5–10 days.
Co-occurring norm
Co-occurring mental health conditions are nearly universal in polysubstance presentations. Treating substance use without addressing depression, anxiety, PTSD, bipolar disorder, ADHD, or personality disorders is a primary driver of relapse.
Naloxone standard
SILC treats any polysubstance presentation as potentially opioid-exposed. Naloxone education, take-home naloxone, and overdose-prevention planning are part of standard programming regardless of the substances the client identifies using.
Section 5
Insurance + cost.
Most major commercial insurance plans cover residential treatment at SILC facilities, including Aetna, Anthem Blue Cross / BCBS plans, Blue Shield of California, Cigna, UnitedHealthcare, Surest, MultiPlan / PHCS, ConnectiCare, Oxford / Harvard Pilgrim, NYSHIP (Empire Plan), Empire BCBS, and Prairie States Enterprises. Network status with any given carrier varies by SILC facility and the patient's specific plan.
Out-of-state insurance is commonly accepted under most plans' out-of-state benefit provisions — Empire BCBS (NY), BCBS Texas, BCBS Florida, Aetna nationwide plans, and UnitedHealthcare nationwide plans typically cover treatment at SILC California facilities.
The SILC admissions team verifies your specific benefits, in plain language, before any clinical commitment. Most insured clients pay a manageable share after coverage; private-pay and financing options are available for clients without insurance or whose plans don't cover residential treatment at the clinically indicated level.
See all accepted insurance carriers →Section 6
Where SILC operates.
SILC Health operates licensed substance use treatment programs in two regions: coastal California (San Diego County) and North Georgia (Towns County). Medical detox is available at Cove Detox (Carlsbad), Leucadia Detox (Encinitas), Seaside Detox (Oceanside), Harbor Detox (Dana Point), and Riverfront Recovery Center (Hiawassee, GA). Residential addiction treatment is anchored by Southern California Recovery Centers (Carlsbad) and Riverfront Recovery Center (Hiawassee, GA).
Roughly two-thirds of SILC's California admissions originate from outside California — the climate, the recovery community, the distance from triggers at home, and the depth of California's continuing-care ecosystem are the most common reasons families choose to travel here for treatment. The Riverfront catchment skews more regional — drive-distance from Tennessee, Kentucky, Indiana, and surrounding states.
See all SILC facilities →Related
Dig deeper.
First step
Polysubstance Detox
Medical management of polysubstance withdrawal — timeline, medications, and what to expect.
The diagnosis
Polysubstance rehab
Clinical overview, signs and symptoms, and how this condition is diagnosed.
The setting
Residential Treatment
What residential treatment looks like — daily schedule, therapies, length of stay.
Coverage
Insurance Verification
How SILC verifies your benefits — including out-of-state coverage.
The process
What to Expect
From the first phone call through arrival at the facility — step by step.
Co-occurring
Dual Diagnosis
Treating substance use and mental health conditions together.
FAQ
Frequently asked questions.
- What is polysubstance use disorder?
- Polysubstance use refers to the concurrent use of multiple psychoactive substances. Under DSM-5, each substance use disorder is diagnosed and severity-graded separately, but clinical management addresses the polysubstance picture as a whole — withdrawal protocols, medication-assisted treatment selection, co-occurring care, and continuing-care planning all account for the full presentation.
- Why is polysubstance rehab different from single-substance rehab?
- Multiple substances change the clinical picture substantially. Withdrawal protocols must address each substance, medication-assisted treatment options vary by substance and may need to be combined (e.g., buprenorphine plus naltrexone), the risk profile of any given clinical decision is higher, and continuing-care planning has to account for multiple recovery domains. Most polysubstance presentations require residential or higher levels of care.
- What about fentanyl contamination of other substances?
- Fentanyl contamination of the U.S. drug supply is now widespread — counterfeit pressed pills, cocaine, methamphetamine, and heroin supplies all carry meaningful fentanyl risk. SILC treats any polysubstance presentation as potentially opioid-exposed and includes naloxone education, take-home naloxone, and overdose-prevention planning in standard programming regardless of the substances the client identifies using.
- Will I need medical detox for polysubstance use?
- Most polysubstance presentations involving alcohol, benzodiazepines, or opioids require ASAM Level 3.7 medical detox — medically managed inpatient withdrawal with 24/7 nursing — before transitioning to residential treatment. SILC operates DHCS-licensed medical detox facilities in California (Cove Detox, Leucadia Detox, Seaside Detox, Harbor Detox) and integrates the detox-to-residential pathway clinically.
- How long is residential polysubstance rehab?
- Length of stay is clinically determined by ASAM criteria and is typically longer than single-substance presentations. Most polysubstance clients spend 5–10 days in medical detox, 30 to 90+ days in residential treatment, and then transition through PHP and IOP. Co-occurring mental health conditions and the complexity of the polysubstance picture often warrant longer residential stays.
- What therapies are used in polysubstance rehab?
- Evidence-based modalities include Cognitive Behavioral Therapy (CBT), Dialectical Behavior Therapy (DBT), Motivational Interviewing, contingency management, trauma-focused therapies (EMDR, prolonged exposure, CPT) when trauma is a driver, family systems therapy, and structured recovery skills training. Medication-assisted treatment is selected and combined based on the specific substances involved.
- Does SILC treat polysubstance use with co-occurring mental health conditions?
- Yes. Co-occurring mental health conditions are nearly universal in polysubstance presentations. SILC's integrated dual-diagnosis programs treat both presentations concurrently with psychiatric care, psychotherapy, and medication management. For many clients, the underlying psychiatric condition is what drove the polysubstance use in the first place; treating it is core to lasting recovery.
- Does SILC accept insurance for polysubstance rehab?
- Most major commercial plans cover polysubstance treatment at SILC across the continuum of care (medical detox, residential, PHP, IOP), including Aetna, Anthem Blue Cross / BCBS, Blue Shield, Cigna, UnitedHealthcare, Surest, MultiPlan / PHCS, ConnectiCare, Oxford / Harvard Pilgrim, NYSHIP, Empire BCBS, and Prairie States Enterprises. SILC verifies benefits in plain language during the admissions conversation.
- Can I continue medication-assisted treatment after polysubstance rehab?
- Yes. Medication-assisted treatment continuation is built into the discharge plan when clinically indicated — buprenorphine or naltrexone for opioid use disorder, naltrexone or acamprosate for alcohol use disorder, and other medications as appropriate. SILC coordinates handoff with addiction medicine providers in the client's home metro to ensure no interruption in MAT after discharge.
- What happens after polysubstance rehab ends?
- Continuing care addresses each substance use disorder concurrently: outpatient programming (PHP, then IOP, then standard outpatient), medication-assisted treatment continuation, recovery fellowship participation across applicable communities (AA, NA, MA, CMA, SMART, alternatives), individual therapy, ongoing psychiatric care for co-occurring conditions, and a multi-domain discharge plan that names specific providers and supports. SILC coordinates direct handoff with home-state providers.
Talk to admissions
Recovery starts with a call.
One call confirms benefits, walks through what arrival looks like, and sets a clear plan from detox through aftercare.